OLN · Olin Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.58B | - | $1.71B | $1.76B | $1.64B | - | $1.59B | $1.64B | $1.64B | - |
| Cost of Revenue | $1.51B | - | $1.53B | $1.62B | $1.50B | - | $1.46B | $1.41B | $1.43B | - |
| Gross Profit | $75.80M | - | $134.50M | $237.80M | $207.30M | - | $134.50M | $237.80M | $207.30M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $145.00M | - | $98.10M | $95.20M | $101.00M | - | $111.70M | $94.60M | $101.90M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $117.20M | - | $130.20M | $129.00M | $132.20M | - | - | - | $129.70M | - |
| Operating Income | ($78.30M) | - | $82.80M | $35.30M | $43.70M | - | $15.50M | $136.40M | $97.30M | - |
| Interest Expense | $43.20M | - | $46.80M | $46.80M | $48.50M | - | $48.40M | $46.60M | $44.60M | - |
| Income Tax | ($35.30M) | - | ($2.20M) | ($4.00M) | $900.0K | - | $0 | $24.30M | $12.50M | - |
| Net Income | ($83.00M) | - | $42.80M | ($1.30M) | $1.20M | - | ($24.90M) | $74.20M | $47.80M | - |
| EPS - Basic | ($0.73) | - | $0.37 | ($0.01) | $0.01 | - | ($0.21) | $0.63 | $0.41 | - |
| EPS - Diluted | ($0.73) | - | $0.37 | ($0.01) | $0.01 | - | ($0.21) | $0.62 | $0.40 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $192.20M | $167.60M | $140.30M | $223.80M | $174.00M | $175.60M | $225.90M | $182.10M | $150.90M | $170.30M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | $827.20M | $784.50M | $966.90M | $919.10M | $875.20M | $823.50M | $827.70M | $872.90M | $823.90M | $858.80M |
| Accounts Payable | $911.40M | $806.10M | $845.70M | $901.00M | $812.00M | $861.60M | $759.10M | $779.10M | $763.70M | $775.40M |
| Current Assets | $2.10B | $1.97B | $2.26B | $2.29B | $2.25B | $2.08B | $2.00B | $2.06B | $1.95B | $1.97B |
| Total Assets | $7.35B | $7.33B | $7.60B | $7.67B | $7.66B | $7.58B | $7.52B | $7.66B | $7.61B | $7.71B |
| Current Liabilities | $1.54B | $1.63B | $1.45B | $1.55B | $1.44B | $1.63B | $1.43B | $1.44B | $1.42B | $1.53B |
| Long-term Debt | $3.00B | $2.72B | $2.97B | $2.98B | $3.02B | $2.71B | $2.77B | $2.79B | $2.68B | $2.59B |
| Total Liabilities | $5.62B | $5.46B | $5.61B | $5.68B | $5.62B | $5.52B | $5.43B | $5.49B | $5.40B | $5.44B |
| Stockholders' Equity | $1.73B | $1.84B | $1.96B | $1.96B | $2.01B | $2.02B | $2.06B | $2.14B | $2.17B | $2.23B |
| Retained Earnings | $2.03B | $2.14B | $2.31B | $2.29B | $2.32B | $2.36B | $2.41B | $2.49B | $2.54B | $2.58B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($48.60M) | - | - | - | ($86.00M) | - | - | - | $81.00M | - |
| Investing Cash Flow | ($43.00M) | - | - | - | ($62.40M) | - | - | - | ($74.70M) | - |
| Financing Cash Flow | $116.20M | - | - | - | $146.60M | - | - | - | ($25.30M) | - |
| CapEx | $61.40M | - | - | - | $61.40M | - | - | - | $44.30M | - |
| Free Cash Flow | ($110.00M) | - | - | - | ($147.40M) | - | - | - | $36.70M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 4.8% | - | 7.9% | 13.5% | 12.6% | - | 8.5% | 14.5% | 12.7% | - |
| Operating margin | -4.9% | - | 4.8% | 2.0% | 2.7% | - | 1.0% | 8.3% | 5.9% | - |
| EBITDA margin | 2.5% | - | 12.4% | 9.3% | 10.7% | - | - | - | 13.9% | - |
| Net margin | -5.2% | - | 2.5% | -0.1% | 0.1% | - | -1.6% | 4.5% | 2.9% | - |
| Free cash flow margin | -6.9% | - | - | - | -9.0% | - | - | - | 2.2% | - |
| FCF / Net income | 1.33 | - | - | - | -122.83 | - | - | - | 0.77 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 9.2% | - | 5.7% | 5.4% | 6.1% | - | 7.0% | 5.8% | 6.2% | - |
| Effective tax rate | - | - | -5.4% | - | 42.9% | - | - | 24.7% | 20.7% | - |
| Return on assets | -1.1% | - | 0.6% | -0.0% | 0.0% | - | -0.3% | 1.0% | 0.6% | - |
| Return on equity | -4.8% | - | 2.2% | -0.1% | 0.1% | - | -1.2% | 3.5% | 2.2% | - |
| Return on invested capital | -1.3% | - | 1.7% | 0.6% | 0.5% | - | 0.3% | 2.1% | 1.6% | - |
| Liquidity | ||||||||||
| Current ratio | 1.36 | 1.21 | 1.56 | 1.48 | 1.56 | 1.27 | 1.40 | 1.43 | 1.38 | 1.29 |
| Quick ratio | 0.82 | 0.73 | 0.89 | 0.88 | 0.96 | 0.77 | 0.82 | 0.82 | 0.80 | 0.73 |
| Cash ratio | 0.12 | 0.10 | 0.10 | 0.14 | 0.12 | 0.11 | 0.16 | 0.13 | 0.11 | 0.11 |
| Leverage | ||||||||||
| Debt / Equity | 1.73 | 1.48 | 1.52 | 1.52 | 1.50 | 1.34 | 1.34 | 1.31 | 1.24 | 1.16 |
| Debt / Assets | 0.41 | 0.37 | 0.39 | 0.39 | 0.39 | 0.36 | 0.37 | 0.36 | 0.35 | 0.34 |
| Debt / EBITDA | 77.02 | - | 13.96 | 18.12 | 17.15 | - | - | - | 11.83 | - |
| Interest coverage | -1.8x | - | 1.8x | 0.8x | 0.9x | - | 0.3x | 2.9x | 2.2x | - |
| Equity multiplier | 4.24 | 3.98 | 3.87 | 3.92 | 3.82 | 3.75 | 3.66 | 3.59 | 3.50 | 3.46 |
| Liabilities / Assets | 0.76 | 0.74 | 0.74 | 0.74 | 0.73 | 0.73 | 0.72 | 0.72 | 0.71 | 0.71 |
| Efficiency | ||||||||||
| Asset turnover | 0.22 | - | 0.23 | 0.23 | 0.21 | - | 0.21 | 0.21 | 0.21 | - |
| Inventory turnover | 1.82 | - | 1.58 | 1.76 | 1.71 | - | 1.76 | 1.61 | 1.73 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | 200d | - | 231d | 207d | 214d | - | 208d | 227d | 211d | - |
| Days payable outstanding | 221d | - | 202d | 203d | 198d | - | 190d | 202d | 195d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 67.5x | - | 2424.0x | - | - | 76.0x | 147.0x | - |
| P / B | 2.0x | - | 1.5x | 1.2x | 1.4x | - | 2.7x | 2.7x | 3.3x | - |
| P / S | 2.1x | - | 1.7x | 1.3x | 1.7x | - | 3.5x | 3.4x | 4.4x | - |
| EV / EBITDA | 159.1x | - | 26.8x | 30.8x | 32.2x | - | - | - | 42.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -3.7% | - | 7.8% | 7.0% | 0.5% | - | -4.9% | -3.4% | -11.3% | - |
| Revenue CAGR (3y) | -5.0% | - | -9.6% | -12.4% | -12.6% | - | -12.1% | -9.5% | -5.2% | - |
| Revenue CAGR (5y) | -3.8% | - | 3.6% | 7.2% | 2.9% | - | 0.2% | 0.6% | 1.0% | - |
| Gross profit growth (YoY) | -63.4% | - | 0.0% | 0.0% | 0.0% | - | -50.0% | -23.3% | -48.5% | - |
| Operating income growth (YoY) | - | - | 434.2% | -74.1% | -55.1% | - | -90.7% | -37.1% | -57.8% | - |
| Net income growth (YoY) | - | - | - | - | -97.5% | - | - | -48.7% | -69.0% | - |
| EPS growth (YoY) | - | - | - | - | -97.5% | - | - | -45.1% | -65.5% | - |
| EPS CAGR (3y) | - | - | -44.6% | - | -84.1% | - | - | -34.1% | -35.8% | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | 9.9% | - |
| FCF growth (YoY) | 25.4% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | 77.2% | - |
| Book value growth (YoY) | -13.5% | -9.1% | -4.6% | -8.4% | -7.6% | -9.4% | -11.6% | -12.2% | -12.9% | -12.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$6.78B totalChlor Alkali Productsand Vinyls Segment$3.68B · 54.3%
Winchester Segment$1.72B · 25.4%
Epoxy Segment$1.37B · 20.2%
Product / service
$6.78B totalChlorinechlorinederivativesandothercoproducts$2.05B · 30.3%
Causticsoda$1.63B · 24.1%
Militaryandlawenforcement$1.09B · 16.0%
Epoxyresins$807.10M · 11.9%
Commercial$636.40M · 9.4%
Aromaticsandallylics$564.70M · 8.3%
Geographic
$3.68B totalUS$2.53B · 68.6%
Otherforeign$995.30M · 27.0%
Europe$160.00M · 4.3%
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing OLIN Corp against the 5 most active filers in the same SIC group.
Dividends
$0.80/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 14, 2026 | $0.2000 |
| Mar 3, 2026 | $0.2000 |
| Nov 28, 2025 | $0.2000 |
| Aug 28, 2025 | $0.2000 |
| May 15, 2025 | $0.2000 |
| Mar 6, 2025 | $0.2000 |
| Nov 14, 2024 | $0.2000 |
| Aug 8, 2024 | $0.2000 |
| May 8, 2024 | $0.2000 |
| Mar 6, 2024 | $0.2000 |
| Nov 8, 2023 | $0.2000 |
| Aug 9, 2023 | $0.2000 |
| May 10, 2023 | $0.2000 |
| Mar 3, 2023 | $0.2000 |
| Nov 9, 2022 | $0.2000 |
| Aug 9, 2022 | $0.2000 |
| May 9, 2022 | $0.2000 |
| Mar 3, 2022 | $0.2000 |
| Nov 9, 2021 | $0.2000 |
| Aug 9, 2021 | $0.2000 |
| May 7, 2021 | $0.2000 |
| Mar 1, 2021 | $0.2000 |
| Nov 9, 2020 | $0.2000 |
| Aug 7, 2020 | $0.2000 |